Nov 06, 2023 / 01:30PM GMT
Operator
Good morning, everyone, and thank you for joining OptimizeRx third-quarter fiscal 2023 earnings discussion. With us today is the Chief Executive Officer of OptimizeRx, William Febbo. He's joined by Chief Financial Officer, Ed Stelmakh; President, Steve Silvestro; General Counsel, Marion Odence-Ford; and Senior Vice President of Corporate Finance, Andrew D'Silva.
At the conclusion of today's earnings call, I will provide some important cautions regarding the forward-looking statements made by the management during today's call. I would like to remind everyone that today's call is being recorded and will be available for replay via webcast only. Instructions are included in today's press release and in the Investors Section of the company's website. Now I would like to turn the call over to OptimizeRx's CEO, William Febbo. Sir, please go ahead.
William Febbo - OptimizeRx Corp. - CEO & Director
Good afternoon and thank you for joining our third-quarter earnings call. I'm pleased to note that Q3 has been an exciting fiscal and operational turning point
Q3 2023 OPTIMIZERx Corp Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot